Toronto Dominion Bank
MIST icon

Toronto Dominion Bank’s Milestone Pharmaceuticals MIST Stock Holding History

Toronto Dominion Bank’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$893K Hold
750,000
– – ﹤0.01% 1351
2025
Q4 		$1.51M Hold
750,000
– – ﹤0.01% 1177
2025
Q3 		$1.5M Hold
750,000
– – ﹤0.01% 1115
2025
Q2 		$1.46M Hold
750,000
– – ﹤0.01% 1043
2025
Q1 		$600K Hold
750,000
– – ﹤0.01% 1133
2024
Q4 		$1.77M Buy
+750,000
New +$1.29M ﹤0.01% 950

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Toronto Dominion Bank's MIST Position: Q1 2026 in Review

Toronto Dominion Bank held its Milestone Pharmaceuticals (MIST) position steady in Q1 2026 at 750,000 shares worth $893K. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

Toronto Dominion Bank first reported a position in MIST in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.77M in Q4 2024. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Toronto Dominion Bank held 750,000 shares of Milestone Pharmaceuticals worth $893K as of Q1 2026.
  • Toronto Dominion Bank left its Milestone Pharmaceuticals share count unchanged in Q1 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1351 holding.
  • Toronto Dominion Bank first reported a position in Milestone Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Toronto Dominion Bank's Milestone Pharmaceuticals position peaked at $1.77M in Q4 2024.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.